Respiratory Flashcards

1
Q

ECG changes in PH

A

RAD
Tall P in II
Tall R in V1
poor R wave progression
Inferior TWI
RBBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asbestos Related Pleuropulmonary Disease

A
  1. Asbestosis
  2. Pleural disease
    a. Benign asbestos effusion
    b. Focal and diffuse benign pleural plaques
  3. Malignancies
    a. NSCLC
    b. Small cell carcinoma
    c. Mesothelioma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Asbestos Related Malignancy

A

Asbestos exposure RR of lung cancer of 3.5

  • Compared with non-smokers without asbestos exposure,
  • OR 1.70 (95% CI 1.31–2.21) among asbestos-exposed non-smokers,
  • OR 5.65 (95% CI 3.38–9.42) among smokers without asbestos exposure,
  • OR 8.70 (95% CI 5.8–13.10) among asbestos-exposed smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic beryllium disease

Clinical featurs and CT findings

A

Beryllium is used in metal and alloy machine shops, electronics, ceramics, aerospace industries
Clincal features:
- cough and SOB (common)
- fever, night sweats, fatigue

HRCT findings:
- nodules in varying sizes
- thickened septal lines
- ground glass opacities
- cystic cavitation
- bronchial wall thickening
- adenopathy involving the hiulum or mediastinum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABPA diagnostic criteria

A
  1. Asthma or CF
  2. need both: a) positive skin prick test or increased IgE levels to A. fumigatus b) Elevated IgE conc (>1000 IU)
  3. 2/3 of following:
    a. Positive Aspergillus precipitants or IgG to A. fumigatus
    b. Radiology consistent with ABPA
    c. Total Eosinophil count >0.5 x 10^6 ub steroid naive pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ABPA radiology findings

A
  • Proximal cylindrical bronchiectasis
  • Mucus plugging
  • Tree in bud opacity
  • Atelectasis
  • Peripheral consolidation
  • Ground glass opacity
  • Mosaic attenuation with gas trapping
  • CT is normal in ~20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Positive prognostic factors for Sarcoid

A

<40years
Asymptomatic LN on chest imaging
Acute inflammatory manifestation
Lack of evidence of organ failure or progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Negativeprognostic factors for Sarcoid

A
  • Age>40
  • Pulm fibrosis on CT
  • Lung function impairment
  • Pulm. HTN
  • Extrapulmonary involvement
  • Lupus pernio
  • Chronic hypercalcaemia
  • Cystic bone lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CF mutation types:

A

Type 1: no functional CFTR
Type 2: F508del defect trafficking - most common
Type 3: G551D defect channel opening
Type 4: defect in conduction
Type 5: low quantity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Microscopic changes in lung with ageing

recoil, collagen, aveoli, compliance

A

Old:
reduced recoil
increased compliance
reduced aveoli volume
reduced collagen1 and increased collagen 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors associated with an increased incidence of HAPE

A

Male
cold ambient temperatures
preexisting respiratory infection
vigorous exertion

Preexisting conditions or anatomic abnormalities that lead to increased pulmonary blood flow, pulmonary hypertension, or increased pulmonary vascular reactivity may predispose to HAPE, even at altitudes below 2500 m. These include:
1. primary pulmonary hypertension
2. congenital absence of one pulmonary artery
3. left-to-right intracardiac shunts, such as atrial septal defects and ventricular septal defects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Haemophilus influenzae on a gram stain

A

Gram -ve bacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Moraxella catarrhalis on a gram stain

A

Gram negative diplicoccus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which lung nodule does not need FU?

A

solid nodules 6 mm or less in diameter in low-risk adults >35 years old generally need no further follow-up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Low glucose in pleural fluid?

A

Malignancy
TB
SLE
Oesophageal rupture
RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of isoniazid resistance in TB?

A

Isoniazid acts by inhibiting the synthesis of mycolic acids through the NADH-dependent enoyl-acyl carrier protein (ACP)-reductase. This drug requires the activity of mycobacterium catalase peroxidase to be activated, therefore mutations in the enzyme lead to drug resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What causes rifampicin resistance in TB?

A

Mutation in RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the RAPID score?

A

looks at the individual factors in infected pleural effusion that confers an adverse prognosis
- Advanced age
- absence of purulent fluid
- low albumin
- increased serum urea
- presence of hospital acquired infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mycophenolate is not used routinely as studies have shown inferiority compared to AZA- which condition?

A

GPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Direct vs indirect provocation tests

A

Direct: methacholine, histamine
- sensitive, not specific
- use bronchodilators

Indirect: hypertonic saline, mannitol, adenosine
- specific for inflammation, thus asthma
- use ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

COPD triple therapy

LAMA/LABA/ICS

A

reduced mod-severe exacerbation
reduced hospitalisation
better lung function

BUT, increased pneumonia (even cf LABA/ICS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CI for spirometry

A
  • High: recent MI, PE, AAA, pneuomothorax
    Acute illness (relative)
    SBP >200 or DBP >120
  • Mod: major thoracic, abdominal, head surgery
  • Less serious surgical procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RF for group 1 PAH

A

CTD: SSc, Raynaud’s SLE, MCTD, RA
HIV
Portal HTN
CHD: septal defect, Eisenmenger syndrome
Schistosomiasis (most common worldwide)

Drugs:
- Dasatinib
- Toxic rapeseed oil
- Methampetamines

Possible:
- Leflunamide
- Alkylating agents
- IF alpha/beta
- Amphetamines
- St John’s wort
- L-tryptophan
- Cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

BMPR2 mutation

A
  • accounts for 70-80% of familial PAH (type1)
    but only 25% with BMPR2 mutation develop PAH
  • Tend to present early, more severe dx, increased risk of death

AD with incomplete penetrance

Other genes: ALK1, ACVRL1, 5HTT, ENG, SMAD9, KCNK3, CAV 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

RF for CTEPH

A

pro-coagulant state
Lupus anticoagulant
APS
Splectomy
indwelling IV line
Permenant IV devices
IBD
PCRV and ET
Malignancy
**High dose thyroid replacement **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

PVOD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is selxipag?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Primary ciliary dyskinesia

A

Agenesis of frontal sinues
absent dynein arm
Abnormal real time electron microscopy study of nasal biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Narcolepsy and HLA

A

HLA DR2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Can PJP be culutred?

A

Pneumocystis cannot be cultured, the diagnosis relies upon the visualization of the cystic or trophic forms in appropriate specimens. Stains that have commonly been used selectively stain the cell wall of the cystic form, and include **Gomori-methenamine silver **

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What’s the first line treatement of cataplexy?

A

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Treatment of narcolepsy without cataplexy?

A

Modafinil is first line for the somnolence associated with narcolepsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Pregnancy and lung function?

A
  1. The forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio, and peak expiratory flow do not change significantly during normal pregnancy.
  2. Residual volume** (RV) and functional residual capacity (FRC)** decrease during pregnancy, while total lung capacity (TLC) decreases only slightly in the last trimester
  3. Minute ventilation increases during pregnancy, associated with increased tidal volume, presumably due to increased circulating levels of progesterone. Thus, normal pregnancy is associated with a **compensated respiratory alkalosis. **
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Change in sleep with age:

A
  • total sleep time decreases
  • sleep onset or latency becomes delayed
  • there is an increase in daytime napping
  • increase in awakenings and arousals
  • decreased sleep efficiency
    **- increased stage 1 and 2 sleep
  • decreased stage 3 and 4 (slow wave sleep)
  • decrease in REM sleep **
  • there is fewer sleep cycles at night. The circadian phase is also typically advanced (ie early to bed and early to rise)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

VTE risk with pregnancy

A

The risk of VTE is increased equally across all three trimesters, however the risk is highest post partum (with VTE risk increasing 4x)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

HAPE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

HACE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

LENT score

when do you use it?
what’s in it?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Riociguat

A

Stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.

40
Q

CI to lung cancer surgery

A

SVC obstruction, FEV < 1.5, MALIGNANT pleural effusion, and vocal cord paralysis

41
Q

What are typical CT findings for UIP?

A

Honey combing
Traction bronchiectasis
Lower lobe and peripheral predominance
No atypical features

42
Q

Features that suggest UIP is unlikely

A

Subpleural sparing
Peribrochovascular predominance
Groundglass separate from honeycombing
Mosaic attenuation
Cysts
Diffuse nodules
Consolidation

43
Q

RF for IPF

A

Age 50-70
Male
past smoking history
no alternative cause

44
Q

Tell me about PALM

A

It’s sporadic cystic lung disease
associated with tuberous sclerosis complex
on CT you can see DIFFUSE bilateral cystic disease
FEMALES only
Associated with angiomyolipomas in the kidneys and meningiomas
complications: chylothorax, pneumothorax
Tx:
- Lung transplant
- Sirolimus

45
Q

LIP

A
46
Q

LCHC

A
47
Q

What causes plateuing of inspiratory loop but not expiratory (variable extrathoracic obstruction):

A

Vocal cord paralysis - unilateral

48
Q

In a flow vol loop

A

Normal inspiration: variable intrathoracic problem - trachiomalacia
Normal expirtion: variable extrathoracic problem
Both affected: fixed

49
Q

Low DLCO, but high KCO

A

think loss of lung:
- prev. lobectomy
- severe pleural disease
- Kyphoscoliosis
- Diaphragmantic paralysis

50
Q

Increased DLCO

A

SAMPLE:
- severe obesity
- asthma
- Mild LVF
- POlycythaemia
- Pulm. haemorrhage
- L->R intracardiac shunt
- Exercise

51
Q

which drug to avoid in narcolepsy

A

Prazosin

52
Q

serum neuron specific enolase: which cancer is it associated with

A

SCLC

53
Q

Hounsfield units; when is it used

A

Nodules - >164 is likely to be benign

54
Q

poor prognostic factors in CF

A

Low FEV1, High CO2, High WCC, Female

55
Q

Elexacaftor/Ivacaftor/Tezacaftor - are beneficial in which phenotype?

A

Phe508del - gating or residual function

56
Q

What is the most common symptom in bronchiectasis>

A

productive cough

57
Q

CT features of bronchiectasis:

A

Bronchoarterial ratio>1
Lack of airway tapering
Airway visibility within 1cm of the costal pleural margin
Touching the mediastinal pleura

Indirect signs:
-bronchial wall thickening
-Mucus impaction
-Mosaic perfusion/air trapping on exp. CT

58
Q

What is a signet ring sign on CT-chest?

A

Associated with bronchiectasis - where the bronchi is much larger than the associated blood vessel

59
Q

Common causes of bronchiectasis:

A
  • Idiopathic (40%)
  • Post infectious (30%)
  • Immunodef
  • COPD
  • CTD
  • ABPA
  • PCD
  • Asthma
  • NT mycobacteria
60
Q

Lung function and primary immunodeficiency?

A

Primary immunodeficiency is associated with worseing lung fucntion - esp XLA
High dose IVIG has shown to be helpful in reducing the rate of decline

61
Q

Bronchiectasis overlap sx

BE-RA
BE-COPD

A

worse outcome

62
Q

Bronchiectasis severity score

A

Age, BMI, FEV1
Hospital admission, # of exacerbation
MRC score
P.aeruginosa
Other organism
CT severity

63
Q

Which Ig def is associated with increased exacerbation in BE?

A

IgG2

64
Q

Macrolide for exacerbation prevention

Azithromycin

A
  • Both immunomodulatory effect and antibacterial effect
  • Azithromycin 500mg 3 x week showed reduction in frequency of exacerbation
  • But, no difference in:
  • FEV1, QoL (but longterm macrolide use improved QoL), colonisation, sx
  • greater benefit in pseudomonas colonisers
65
Q

The effect of pseudomonas in BE

A
  • worse mortality and morbidity
66
Q

CF diagnostic criteria

A
  1. 1 or more:
    -classic phenotype
    - sibling with CF
    - positive newborn screen

2.>1:
- abnormal sweat test on 2 or more occasions
- 2 CFTR variants identified
- abnormal nasal potential differential testing

67
Q

What’s the chloride level on sweat test signficant for CF?

A

> 60 = highly likely
<29 = unlikely

68
Q

What are the 2 most common clinical manifestation of CF?

A

Sinusitis
MAle infertility

69
Q

Pseudomonas and CF?

A

70% of CF adults are chronically colonised
Mucoid phenotype is associated with worse lung fucntion

70
Q

Azithromycin in CF

A
  • Improves FEV1
  • Reduced exacerbation
  • -antibacterial effcet against pseudomonas
  • anti inflammatory effect
  • reduces biofilm production

DO NOT USED in NT mycobacterium colonised pt as increased risk of resistance

71
Q

Airway secretion management in CF?

A

inhaled Dornase alpha:
- reduced exac
- improved FEV1
- improves QoL

inhaled hypertonic saline
- reduces exac

PEP:
- reduces exac

72
Q

Most frequent pathogen in CF

A
  • Staph aereus ealier in life
  • then pseudomonas after 35

Haemophilus is higher in early life subsides after teenage

73
Q

Burkholderia cepacia complex in CF

A
  • Chronic infection results in **accelerated decline **in lung function and
    shortened survival
  • Usually, multi-drug resistant
    * Worse outcomes with lung transplantation esp with B. cenocepacia
  • Infection control measures to prevent cross infection between CF patients
74
Q

*Non-tuberculous mycobacteria in CF: 10-20%

A

MAC is not assocaited with worse transplant outcome
M. abscessus IS associated with worse lung fucntion and transplant outcome

75
Q

Ivacaftor and G551D mutation

A

G551D mutation is assocaited with Type 3 CF
- defect in channel opening
- Ivacaftor has shown to improve FEV1, reduced exac risk, reduce hospitalisation
- resutls in weight gain (which is good for CF pts)

76
Q

Lumacaftor and Ivacaftor in DeltaF508

A

Detla F508 is the most common mutation in CF
Type 2 CF - problem with misfolding od protein and trafficking to mb
Lumacaftor partially corrects the misfolding and Ivacaftor helps with channel opening

Small improvement in FEV1, QoL and BMI
Reduced exac risk
but ~15% don’t tolerate it

In heterozygote the only improvement was int he sx score and sweat chloride level

77
Q

Tezacaftor/Ivacaftor data

A

In F508 homozygotes:
- improved QoL, exac, FEV1 but not change BMI

in F508 hetero:
- the combo showed improvedment in FEV1 and QoL
- cf. ivacaftor monotherapy and placebo

78
Q

Elexacaftor/Teza/Ivacaftor

A

in delta F508:
Heterozygotes: improved cl transport to ~50% of normal
Improved FEV1 and reduced exac
Homozygotes: improved it to >50%
improved QoL

In homozygotes:
Triple therapy cf Teza/Iva: improved FEV1 by 10% and QoL

Triple therapy in F508 mutation:
- improved FEV1 by ~15%
- Weight gain
- reduced LTOT, noctural NIV need, PEG feeding, transplant

79
Q

Positional OSA is more prevalent in young and non-obese pts

A

REM OSA is more common in female and is associated with HTN, CVD, neurocognitive sx, insulin resistance

80
Q

OSA with COPD –> increased risk of death and exacerbations

A

In HF, OSA or CSA increases mortality risk

In diabetes, CPAP improves glycaemic control

81
Q

OSA is common in non-dialysis CKD

A

OSA and hypoxia may predispose to NASH in severe obesity

82
Q

Increasing OSA severity is associated with increased risk of HTN

A
83
Q

Benefit of wt loss in OSA

A

10% weight loss –> 25% improvement in OSA

84
Q

Does CPAP have an effect on HbA1c

A

no

85
Q

Proven benefit of CPAP

A

Reduced AHI
Improves symptoms
Reduced MVA
Improves erectile dysfunction
Improves QoL
Improves insulin resistance in non-diabetics with OSA

Potential improvement in HTN; more beneficial in more severe OSA with high baseline BP or resistant HTN

86
Q

OSA and CVD evidence

A
  1. reduced risk of revascularisation after PTCA in CPAP treated OSA pt
  2. CPAP modestly lowers BP by 2-4mmHg in pts with mod-severe OSA
  3. CPAP did not reduce cardiovascular events in secondary prevention trial in mod-severe OSA

  1. Retrospective study
  2. There was an observational study that showed benefit with CPAP
87
Q

Oral appliances and OSA

A

reduces AHI
useful in all severity but less responsive cf. CPAP in mod-severe OSA
reduction in AHI with CPAP is greater, but OA has a better compliance
improves QoL

88
Q

Risk factors for CSA and CSR in HF

A

Male, >60
AF, low LVEF, daytime hypocapnia PaCO2<38

89
Q

RLS is associated with

Willis-Ekbom sx

A

iron deficiency
Coeliac
ADHD
COPD
Depression/Panic
Fribromyalgia
PD
MS
Migraines

Drugs:
Dopamine antagonist
SSRIs
Neuroleptics
Lithium
Beta blockers

90
Q

Diagnostic criteria for narcolepsy

A

MSLT<8mins or sleep latency (on PSG) <10min, REM sleep latency <20min

AND:
>2 sleep onset REM

REM within 15mins on PSG is suggestive of narcolepsy

91
Q

REM behavioural disorder

A

-associated with synucleinopathies (LBD, PD, MSA)
- very common with PD
parkinsonism improves during RBD
- can predate dementia by 10years
- lack of REM atonia on PSG

Tx:
- clonazepam
- melatonin

92
Q

Somnambulism

Sleep walking

A

peak incidence 11-12 years
Associated with HLA DQB1
commonly arises in nREM
RF: sleep dep, emotional distress, febrile illness, physical activity

93
Q

Klein-Levin syndrome

A

Periodic hypersomnia

94
Q

HLA association to narcolepsy

A

HLA DQB1*0602
DR3

95
Q

What type of hypersensitivity reaction does ABPA illustrate?

A

Type 1,3, 4b

96
Q

Which ILD resolves with smoking cessation?

A

RBILD and DIP